JMS Co

JMS Co FCF per Share

The Free Cash Flow per Share of JMS Co (7702.T) as of Nov 2, 2026 is -36.36 JPY. In the previous year, Free Cash Flow per Share was -58.34 JPY — a change of -37.66% (higher).

FCF per Share

-36.36JPY

YoY

-37.66%

Last updated:

Free Cash Flow per Share of JMS Co is 2026 -36.36 JPY. Free Cash Flow per Share of JMS Co was 2025 -58.34 JPY. It decreases by -37.66% higher compared to the previous year.

The JMS Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
56.02 JPY
Jan 1, 2020
10.77 JPY
Jan 1, 2021
19.70 JPY
Jan 1, 2022
46.55 JPY
Jan 1, 2023
-43.75 JPY
Jan 1, 2024
20.32 JPY
Jan 1, 2025
-58.34 JPY
Jan 1, 2026
-36.36 JPY
The JMS Co FCF per Share history
YEARFCF per ShareYoY
-36.36JPY-37.66%
-58.34JPY-387.03%
20.32JPY-146.46%
-43.75JPY-193.99%
46.55JPY+136.31%
19.70JPY+82.89%
10.77JPY-80.77%
56.02JPY-605.77%
-11.08JPY+61.62%
-6.85JPY-90.87%
-75.09JPY+157.08%
-29.21JPY-79.73%
-144.13JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Free Cash Flow per Share of JMS Co is -36.36 JPY in 2026.

Free Cash Flow per Share of JMS Co changed from -58.34 JPY to -36.36 JPY, representing a -37.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share JMS Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — JMS Co

All Key Metrics — JMS Co